CathRx

CathRx is an Australian medical device company that specializes in developing and manufacturing advanced electrophysiology catheters and ablation technology for minimally invasive cardiac diagnostics and therapeutics. Founded in 1999, the company is committed to enhancing patient outcomes and clinical efficiency through innovative catheter design and next-generation ablation platforms. The core product offerings include a patented modular ablation platform designed for multiple cardiac arrhythmia indications. This platform was developed in collaboration with leading global physicians and is engineered at their Sydney headquarters. CathRx’s electrophysiology catheters are designed for safety, superior handling, and clinical versatility, allowing one catheter to perform multiple functions. They focus on patient comfort, high-quality signal acquisition for accurate diagnosis, and cost-effectiveness through reusability. CathRx serves hospitals and healthcare providers specializing in cardiac electrophysiology, particularly in diagnosing and treating arrhythmias like atrial fibrillation. The company aims to reduce procedural risks, improve clinical outcomes, and lower healthcare costs with its durable and multifunctional solutions.

• Employees 35
• Founded 1999
• Annual Revenue $10000000